Cargando…

An overview of procurement, pricing, and uptake of COVID-19 vaccines in Pakistan

Detalles Bibliográficos
Autores principales:	Siddiqui, Adeel, Ahmed, Ali, Tanveer, Maria, Saqlain, Muhammad, Kow, Chia Siang, Hasan, Syed Shahzad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324410/ https://www.ncbi.nlm.nih.gov/pubmed/34364719 http://dx.doi.org/10.1016/j.vaccine.2021.07.072

Ejemplares similares

“Sehat Sahulat Program”: A Leap into the Universal Health Coverage in Pakistan
por: Hasan, Syed Shahzad, et al.
Publicado: (2022)

Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2023)

Antimicrobial consumption among hospitalized patients with COVID-19 in Pakistan
por: Ul Mustafa, Zia, et al.
Publicado: (2021)

Cerebral Venous Thrombosis following COVID-19 Vaccination
por: Kow, Chia Siang, et al.
Publicado: (2021)

Potential interactions between COVID-19 vaccines and antiepileptic drugs
por: Kow, Chia Siang, et al.
Publicado: (2021)

The impact of clinical pharmacist services on patient health outcomes in Pakistan: a systematic review
por: Ahmed, Ali, et al.
Publicado: (2021)

Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies
por: Kow, Chia Siang, et al.
Publicado: (2021)

Is Pakistan prepared to tackle the coronavirus epidemic?
por: Saqlain, Muhammad, et al.
Publicado: (2020)

Vaccine Acceptance and Hesitancy among Hospitalized COVID-19 Patients in Punjab, Pakistan
por: Baraka, Mohamed A., et al.
Publicado: (2022)

Can COVID-19 vaccines improve cardiovascular outcomes?
por: Kow, Chia Siang, et al.
Publicado: (2022)

Pattern of medication utilization in hospitalized patients with COVID-19 in three District Headquarters Hospitals in the Punjab province of Pakistan
por: Mustafa, Zia Ul, et al.
Publicado: (2021)

The use of corticosteroids in patients with COVID-19 vaccine–related cerebral venous thrombosis
por: Kow, Chia Siang, et al.
Publicado: (2022)

Melatonin: Revisited Role as Vaccine Adjuvant During Outbreaks of COVID-19 Caused by the Delta Variant
por: Kow, Chia Siang, et al.
Publicado: (2021)

COVID-19 Vaccine Hesitancy among Pregnant Women Attending Antenatal Clinics in Pakistan: A Multicentric, Prospective, Survey-Based Study
por: Mustafa, Zia Ul, et al.
Publicado: (2022)

Macrolides for patients with COVID-19 and concurrent pertussis infection
por: Kow, Chia Siang, et al.
Publicado: (2021)

Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease
por: Kow, Chia Siang, et al.
Publicado: (2020)

Role of frailty in COVID-19 patients
por: Kow, Chia Siang, et al.
Publicado: (2020)

Concurrent Antibiotic Therapy in Disseminated Strongyloidiasis
por: Kow, Chia Siang, et al.
Publicado: (2020)

Pharmacotherapeutic considerations for systemic rheumatic diseases amid the COVID-19 pandemic: more questions than answers
por: Kow, Chia Siang, et al.
Publicado: (2020)

Use of Azithromycin in COVID-19: A Cautionary Tale
por: Kow, Chia Siang, et al.
Publicado: (2020)

Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2021)

Meta-analysis of Effect of Statins in Patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Use of low-molecular-weight heparin in COVID-19 patients
por: Kow, Chia Siang, et al.
Publicado: (2020)

Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic
por: Kow, Chia Siang, et al.
Publicado: (2020)

El uso de agentes antiplaquetarios para la tromboprofilaxis arterial en la COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Optimal time for the resumption of biologics after COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

The use of antimotility drugs in COVID-19 associated diarrhea
por: Kow, Chia Siang, et al.
Publicado: (2021)

Neurohormonal treatment in tako-tsubo cardiomyopathy precipitated by COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Tratamiento neurohormonal en miocardiopatía de tako-tsubo precipitada por COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Azithromycin in patients with COVID-19: Friend or foe?
por: Kow, Chia Siang, et al.
Publicado: (2021)

The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis
por: Kow, Chia Siang, et al.
Publicado: (2020)

Use of DPP-4 inhibitors in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Special consideration in the dosing of medications for patients with COVID-19 and acute kidney injury
por: Kow, Chia Siang, et al.
Publicado: (2020)

The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
por: Kow, Chia Siang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b0t97oqgk7kmd80lhfnltp8oik